Upward Trajectory: ReShape Lifesciences Inc. (RSLS) Posts a Gaine, Closing at 0.20

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The closing price of ReShape Lifesciences Inc. (NASDAQ: RSLS) was $0.20 for the day, up 3.66% from the previous closing price of $0.19. In other words, the price has increased by $3.66 from its previous closing price. On the day, 6.83 million shares were traded. RSLS stock price reached its highest trading level at $0.216 during the session, while it also had its lowest trading level at $0.1861.


Our analysis of RSLS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.26 and its Current Ratio is at 2.24. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.03.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 25 ’23 when STANKOVICH THOMAS sold 131 shares for $0.27 per share. The transaction valued at 35 led to the insider holds 22,949 shares of the business.

STANKOVICH THOMAS sold 39 shares of RSLS for $36 on Oct 11 ’23. The Chief Financial Officer now owns 23,080 shares after completing the transaction at $0.93 per share. On Sep 01 ’23, another insider, STANKOVICH THOMAS, who serves as the Chief Financial Officer of the company, sold 118 shares for $0.89 each. As a result, the insider received 105 and left with 23,119 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RSLS now has a Market Capitalization of 4581171 and an Enterprise Value of 2441169. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.55 while its Price-to-Book (P/B) ratio in mrq is 1.01. Its current Enterprise Value per Revenue stands at 0.293 whereas that against EBITDA is -0.22.

Stock Price History:

The Beta on a monthly basis for RSLS is 1.54, which has changed by -0.88857144 over the last 52 weeks, in comparison to a change of 0.26238096 over the same period for the S&P500. Over the past 52 weeks, RSLS has reached a high of $2.16, while it has fallen to a 52-week low of $0.14. The 50-Day Moving Average of the stock is 3.10%, while the 200-Day Moving Average is calculated to be -25.33%.

Shares Statistics:

RSLS traded an average of 5.59M shares per day over the past three months and 2746220 shares per day over the past ten days. A total of 23.46M shares are outstanding, with a floating share count of 20.81M. Insiders hold about 11.27% of the company’s shares, while institutions hold 1.25% stake in the company. Shares short for RSLS as of 1715731200 were 310621 with a Short Ratio of 0.39, compared to 1713139200 on 487784. Therefore, it implies a Short% of Shares Outstanding of 310621 and a Short% of Float of 1.48.

Earnings Estimates

Current recommendations for the stock of the company come from 1.0 analysts. On average, analysts expect EPS of -$0.12 for the current quarter, with a high estimate of -$0.12 and a low estimate of -$0.12, while EPS last year was -$1.08. The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.1 and low estimates of -$0.1.

Analysts are recommending an EPS of between -$0.45 and -$0.45 for the fiscal current year, implying an average EPS of -$0.45. EPS for the following year is -$0.36, with 1.0 analysts recommending between -$0.36 and -$0.36.

Revenue Estimates

For the next quarter, 1 analysts are estimating revenue of $2.51M. There is a high estimate of $2.51M for the next quarter, whereas the lowest estimate is $2.51M.

A total of 1 analysts have provided revenue estimates for RSLS’s current fiscal year. The highest revenue estimate was $9.99M, while the lowest revenue estimate was $9.99M, resulting in an average revenue estimate of $9.99M. In the same quarter a year ago, actual revenue was $8.68MBased on 1 analysts’ estimates, the company’s revenue will be $11.99M in the next fiscal year. The high estimate is $11.99M and the low estimate is $11.99M.

Most Popular